Perspectives on genetic and genomic technologies in an academic medical center: The duke experience

Journal of Personalized Medicine

Volumn 5, Issue 2, 2015, Pages 67-82

  Katsanis, Sara Huston ^a,b   Minear, Mollie A ^a,b   Vorderstrasse, Allison ^a,b   Yang, Nancy ^c   Reeves, Jason W ^d   Rakhra Burris, Tejinder ^a   Cook Deegan, Robert ^a,b   Ginsburg, Geoffrey S ^a   Simmons, Leigh Ann ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d SANOFI   (United States)

Author keywords

Clinical implementation; Genetic tests; Genomic tests; Knowledge gaps; Personalized medicine; Pharmacogenetics; Physician education; Return of research results

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CLINICAL RESEARCH; GENETICS; GENOMICS; HEALTH CARE PRACTICE; HEALTH SURVEY; HUMAN; PERSONALIZED MEDICINE; PHARMACOGENETICS; QUESTIONNAIRE; STATISTICAL ANALYSIS; UNIVERSITY HOSPITAL;

EID: 85007201789     PISSN: None     EISSN: 20754426     Source Type: Journal    
DOI: 10.3390/jpm5020067     Document Type: Article

References (54)

1. Ginsburg, G.S. Realizing the opportunities of genomics in health care. JAMA 2013, 309, 1463-1464.
2. Manolio, T.A.; Chisholm, R.L.; Ozenberger, B.; Roden, D.M.; Williams, M.S.; Wilson, R.; Bick, D.; Bottinger, E.P.; Brilliant, M.H.; Eng, C.; et al. Implementing genomic medicine in the clinic: The future is here. Genet. Med. 2013, 15, 258-267.
3. Haga S.B. Delivering pharmacogenetic testing to the masses: An achievable goal? Pharmacogenomics 2014, 15, 1-4.
4. Snyderman, R. Personalized health care: From theory to practice. Biotechnol. J. 2012, 7, 973-979.
5. Kawamoto K.; Lobach D.F.; Willard H.F.; Ginsburg G.S. A national clinical decision support infrastructure to enable the widespread and consistent practice of genomic and personalized medicine. BMC Med. Inf. Decis. Mak. 2009, 9, e17.
6. Chen R.; Mias G.I.; Li-Pook-Than J.; Jiang L.; Lam H.Y.; Chen R.; Miriami E.; Karczewski K.J.; Hariharan M.; Dewey F.E. ;et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell 2012, 148, 1293-1307.
7. Kho, A.N.; Pacheco, J.A.; Peissig, P.L.; Rasmussen, L.; Newton, K.M.; Weston, N.; Crane, P.K.; Pathak, J.; Chute, C.G.; Bielinski, S.J. ; et al. Electronic medical records for genetic research: Results of the emerge consortium. Sci. Transl. Med. 2011, 3, doi:10.1126/scitranslmed.3001807.
8. Verschuren, J.J.; Trompet, S.; Wessels, J.A.; Guchelaar, H.J.; de Maat, M.P.; Simoons, M.L.; Jukema, J.W. A systematic review on pharmacogenetics in cardiovascular disease: Is it ready for clinical application? Eur. Heart J. 2012, 33, 165-175.
9. Feng, X.; Brazill, B.; Pearson, D. Therapeutic application of pharmacogenomics in oncology: Selective biomarkers for cancer treatment. US Pharm. 2011, 36, 5-12.
10. Haas, D.W.; Kuritzkes, D.R.; Ritchie, M.D.; Amur, S.; Gage, B.F.; Maartens, G.; Masys, D.; Fellay, J.; Phillips, E.;Ribaudo, H.J.; et al; Pharmacogenomics of hiv therapy: Summary of a workshop sponsored by the national institute of allergy and infectious diseases. HIV Clin Trials 2011, 12, 277-285.
11. Crews, K.R.; Hicks, J.K.; Pui, C.H.; Relling, M.V.; Evans, W.E. Pharmacogenomics and individualized medicine: Translating science into practice. Clin. Pharmacol. Therap. 2012, 92, 467-475.
12. Kho, A.N.; Rasmussen, L.V.; Connolly, J.J.; Peissig, P.L.; Starren, J.; Hakonarson, H.; Hayes, M.G. Practical challenges in integrating genomic data into the electronic health record. Genet. Med. 2013, 15, 772-778.
13. Pisanu, C.; Tsermpini, E.E.; Mavroidi, E.; Katsila, T.; Patrinos, G.P.; Squassina, A. Assessment of the pharmacogenomics educational environment in southeast Europe. Public Health Genomics 2014, 17, 272-279.
14. Scott, S.A. Clinical pharmacogenomics: Opportunities and challenges at point of care. Clin. Pharmacol. Therap. 2013, 93, 33-35.
15. Mills, R.; Haga, S.B. Clinical delivery of pharmacogenetic testing services: A proposed partnership between genetic counselors and pharmacists: Pharmacogenomics 2013, 14, 957-968.
16. Dressler, L.G. Integrating personalized genomic medicine into routine clinical care: Addressing the social and policy issues of pharmacogenomic testing. N. C. Med. J. 2013, 74, 509-513.
17. Green, R.C.; Berg, J.S.; Grody, W.W.; Kalia, S.S.; Korf, B.R.; Martin, C.L.; McGuire, A.L.; Nussbaum, R.L.; O’Daniel, J.M.; Ormond, K.E.; et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. Genet. 2013, 15, 565-574.
18. Allyse, M.; Michie, M. Not-so-incidental findings: The ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing. Trends Biotechnol. 2013, 31, 439-441.
19. Burke, W.; Matheny Antommaria, A.H.; Bennett, R.; Botkin, J.; Clayton, E.W.; Henderson, G.E.; Holm, I.A.; Jarvik, G.P.; Khoury, M.J.Knoppers, B.M.; et al.; Recommendations for returning genomic incidental findings? We need to talk!. Genet. Med. 2013, 15, 854-859.
20. Rosenblatt, D.S. Who’s on first in exome and whole genome sequencing? Is it the patient or the incidental findings?. Mol. Genet. Metab. 2013, 110, 1-2.
21. Jarvik, G.P.; Amendola, L.M.; Berg, J.S.; Brothers, K.; Clayton, E.W.; Chung, W.; Evans, B.J.; Evans, J.P.; Fullerton, S.M.; Gallego, C.J.; et al; Return of genomic results to research participants: The floor, the ceiling, and the choices in between. Am. J. Hum. Genet. 2014, 94, 818-826.
22. McGuire, A.L.; Knoppers, B.M.; Zawati, M.H.; Clayton, E.W. Can I be sued for that? Liability risk and the disclosure of clinically significant genetic research findings. Genome Res. 2014, 24, 719-723.
23. Wolf, S.M. Return of individual research results and incidental findings: Facing the challenges of translational science. Annu. Rev. Genomics Hum. Genet. 2013, 14, 557-577.
24. Knoppers, B.M.; Joly, Y.; Simard, J.; Durocher, F. The emergence of an ethical duty to disclose genetic research results: International perspectives. Eur. J. Hum. Genet. 2006, 14, 1170-1178.
25. Dal-Re, R.; Katsanis, N.; Katsanis, S.; Parker, L.S.; Ayuso, C. Managing incidental genomic findings in clinical trials: Fulfillment of the principle of justice. PLOS Med. 2014, 11, e1001584.
26. Angrist, M.; Jamal, L. Living laboratory: Whole-genome sequencing as a learning healthcare enterprise. Clin. Genet. 2014, 87, 311-318.
27. Berg, J.S.; Amendola, L.M.; Eng, C.; van Allen, E.; Gray, S.W.; Wagle, N.; Rehm, H.L.; deChene, E.T.; Dulik, M.C.; Hisama, F.M.; et al; Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the clinical sequencing exploratory research consortium. Genet. Med. 2013, 15, 860-867.
28. Ramos, E.M.; Din-Lovinescu, C.; Berg, J.S.; Brooks, L.D.; Duncanson, A.; Dunn, M.; Good, P.; Hubbard, T.J.; Jarvik, G.P.; O’Donnell, C.; et al. Characterizing genetic variants for clinical action. Am. J. Med. Genet. Part C Semin. Med. Genet. 2014, 166C, 93-104.
29. Lawrence, L.; Sincan, M.; Markello, T.; Adams, D.R.; Gill, F.; Godfrey, R.; Golas, G.; Groden, C.; Landis, D. Nehrebecky, M.; et al; The implications of familial incidental findings from exome sequencing: The NIH undiagnosed diseases program experience. Genet. Med. 2014, doi:10.1038/gim.2014.29.
30. Tabor, H.K.; Auer, P.L.; Jamal, S.M.; Chong, J.X.; Yu, J.H.; Gordon, A.S.; Graubert, T.A.; O’Donnell, C.J.; Rich, S.S.; Nickerson, D.A.;et al. Pathogenic variants for mendelian and complex traits in exomes of 6517 european and african americans: Implications for the return of incidental results. Am. J. Hum. Genet. 2014, 95, 183-193.
31. Ginsburg, G.S.; McCarthy, J.J. Personalized medicine: Revolutionizing drug discovery and patient care. Trends Biotechnol. 2001, 19, 491-496.
32. Tenenbaum, J.D.; Christian, V.; Cornish, M.A.; Dolor, R.J.; Dunham, A.A.; Ginsburg, G.S.; Kraus, V.B.; McHutchison, J.G.; Nahm, M.L.; Newby, L.K.; et al. The murdock study: A long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records. Am. J. Transl. Res. 2012, 4, 291-301.
33. Simmons, L.A.; Wolever, R.Q.; Bechard, E.M.; Snyderman, R. Patient engagement as a risk factor in personalized health care: A systematic review of the literature on chronic disease. Genome Med. 2014, 6, e16.
34. Yang, N.Y.; Wroth, S.; Parham, C.; Strait, M.; Simmons, L.A. Personalized health planning with integrative health coaching to reduce obesity risk among women gaining excess weight during pregnancy. Global Adv. Health Med.. 2013, 2, 72-77.
35. Vorderstrasse, A.A.; Ginsburg, G.S.; Kraus, W.E.; Maldonado, M.C.; Wolever, R.Q. Health coaching and genomics-potential avenues to elicit behavior change in those at risk for chronic disease: Protocol for personalized medicine effectiveness study in air force primary care. Glob. Adv. Health Med. 2013, 2, 26-38.
36. U.S. Food and Drug Administration. Table of pharmacogenomic biomarkers in drug labeling. Available online: http://www.fda.gov/drugs/scienceresearch/researchareas/pharmacogenetics/ucm083378.htm (accessed on 27 September 2014).
37. PharmGKB. Drug labels. Available online: https://www.pharmgkb.org/view/drug-labels.do (accessed on 27 September 2014).
38. Buchanan, A.H.; Christianson, C.A.; Himmel, T.; Powell, K.P.; Agbaje, A.; Ginsburg, G.S.; Henrich, V.C.; Orlando, L.A. Use of a patient-entered family health history tool with decision support in primary care: Impact of identification of increased risk patients on genetic counseling attendance. J. Genet. Couns. 2015, 24, 179-188.
39. Haga, S.; Burke, W.; Ginsburg, G.; Mills, R.Agans, R.; Primary care physicians’ knowledge of and experience with pharmacogenetic testing. Clin. Genet. 2012, 82, 388-394.
40. McCarthy, J.J.; McLeod, H.L.; Ginsburg, G.S. Genomic medicine: A decade of successes, challenges, and opportunities. Sci. Transl. Med. 2013, 5, doi:10.1126/scitranslmed.3005785.
41. Savage, S.K.; Ziniel, S.I.; Stoler, J.; Margulies, D.M.; Holm, I.A. Brownstein, C.; An assessment of clinician and researcher needs for support in the era of genomic medicine. Pers. Med. 2014, 11, 569-579.
42. Hicks, J.K.; Crews, K.R.; Hoffman, J.M.; Kornegay, N.M.; Wilkinson, M.R.; Lorier, R.; Stoddard, A.; Yang, W.; Smith, C.; Fernandez, C.A.; et al. A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record. Clin. Pharmacol. Therap. 2012, 92, 563-566.
43. Overby, C.L.; Kohane, I.; Kannry, J.L.; Williams, M.S.; Starren, J.; Bottinger, E.; Gottesman, O.; Denny, J.C.; Weng, C. Tarczy-Hornoch, P.; et al; Opportunities for genomic clinical decision support interventions. Genet. Med. 2013, 15, 817-823.
44. Salari, K. The dawning era of personalized medicine exposes a gap in medical education. PLOS Med. 2009, 6, e1000138.
45. Rasmussen-Torvik, L.J.; Stallings, S.C.; Gordon, A.S.; Almoguera, B.; Basford, M.A.; Bielinski, S.J.; Brautbar, A.; Brilliant, M.H.; Carrell, D.S.; Connolly, J.J.; et al. Design and anticipated outcomes of the emerge-PGX project: A multicenter pilot for preemptive pharmacogenomics in electronic health record systems. Clin. Pharmacol. Ther. 2014, 96, 482-489.
46. Sturm, A.C.; Sweet, K.; Manickam, K. Implementation of a clinical research pharmacogenomics program at an academic medical center: Role of the genetics healthcare professional. Pharmacogenomics 2013, 14, 703-706.
47. Gottesman, O.; Scott, S.A.; Ellis, S.B.; Overby, C.L.; Ludtke, A.; Hulot, J.S.; Hall, J.; Chatani, K.; Myers, K.; Kannry, J.L.; et al. The clipmerge PGX program: Clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics. Clin. Pharmacol. Ther. 2013, 94, 214-217.
48. Powell, K.P.; Cogswell, W.A.; Christianson, C.A.; Dave, G.; Verma, A.; Eubanks, S.; Henrich, V.C. Primary care physicians’ awareness, experience and opinions of direct-to-consumer genetic testing. J. Genet. Couns. 2012, 21, 113-126.
49. Yu, J.H.; Harrell, T.M.; Jamal, S.M.; Tabor, H.K.; Bamshad, M.J. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing. Am. J. Hum. Genet. 2014, 95, 77-84.
50. Bollinger, J.M.; Scott, J.; Dvoskin, R.; Kaufman, D. Public preferences regarding the return of individual genetic research results: Findings from a qualitative focus group study Genet. Med. 2012, 14, 451-457.
51. Wright, M.F.; Lewis, K.L.; Fisher, T.C.; Hooker, G.W.; Emanuel, T.E.; Biesecker, L.G.; Biesecker, B.B. Preferences for results delivery from exome sequencing/genome sequencing. Genet. Med. 2014, 16, 442-447.
52. Fernandez, C.V.; Bouffet, E.; Malkin, D.; Jabado, N.; O’Connell, C.; Avard, D.; Knoppers, B.M.; Ferguson, M.; Boycott, K.M.Sorensen, P.H. et al; Attitudes of parents toward the return of targeted and incidental genomic research findings in children. Genet. Med. 2014, 16, 633-640.
53. Murphy Bollinger, J.; Bridges, J.F.; Mohamed, A.; Kaufman, D. Public preferences for the return of research results in genetic research: A conjoint analysis. Genet. Med. 2014, 16, 932-939.
54. Barge, S.; Gehlbach, H. Using the theory of satisficing to evaluate the quality of survey data. Res. High. Educ. 2012, 53, 182-200.